Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip Clayton

Showing results (21-30 of 40) with videos related to

Pageof 4
Sort By:
Transplant International : Official Journal of the European Society for Organ Transplantation|February 21, 2012
Lack of impact of donor age on patient survival for renal transplant recipients ≥60yearsWai H Lim, Gursharan Dogra, Steve J Chadban, et al.
Transplantation|October 27, 2018
Everolimus and Long-term Clinical Outcomes in Kidney Transplant Recipients: A Registry-based 10-year Follow-up of 5 Randomized TrialsTracey Ying, Germaine Wong, Wai H Lim, et al.
Transplantation|June 24, 2015
Cancer-Specific and All-Cause Mortality in Kidney Transplant Recipients With and Without Previous CancerAndrea K Viecelli, Wai H Lim, Petra Macaskill, et al.
Pediatric Transplantation|May 4, 2021
Paediatric deceased donor kidney transplant in Australia: A 30-year review-What have paediatric bonuses achieved and where to from here?Matthew P Sypek, Christopher E Davies, Amelia K Le Page, et al.
Clinical Transplantation|June 8, 2012
Human leukocyte antigen mismatches associated with increased risk of rejection, graft failure, and death independent of initial immunosuppression in renal transplant recipientsWai H Lim, Steve J Chadban, Philip Clayton, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|February 4, 2012
Weekend compared with weekday presentations of peritoneal dialysis-associated peritonitisDavid W Johnson, Philip Clayton, Yeoungjee Cho, et al.
JMIR Research Protocols|June 4, 2025
Using Linked Health Service Data in Multimodal Modeling of Kidney Transplant Waitlist Outcomes: Protocol for the Maximizing Organ Donor Utility Systemwide (MODUS) StudyBrenda Maria Rosales, Karan Shah, Nicole De La Mata, et al.
Nephrology (Carlton, Vic.)|January 26, 2016
Peritoneal dialysis practice in Australia and New Zealand: A call to sustain the actionDavid W Mudge, Neil Boudville, Fiona Brown, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 10, 2023
Associations of neutral pH, low-GDP peritoneal dialysis solutions with patient survival, transfer to haemodialysis and peritonitisJenny H C Chen, David W Johnson, Yeoungjee Cho, et al.
Clinical Journal of the American Society of Nephrology : CJASN|September 10, 2011
Effect of dialysis modality on survival of hepatitis C-infected ESRF patientsBhadran Bose, Stephen P McDonald, Carmel M Hawley, et al.
Pageof 4

Showing results (21-30 of 40) with videos related to

Sort By:
Pageof 4
Transplant International : Official Journal of the European Society for Organ Transplantation|February 21, 2012
Lack of impact of donor age on patient survival for renal transplant recipients ≥60yearsWai H Lim, Gursharan Dogra, Steve J Chadban, et al.
Transplantation|October 27, 2018
Everolimus and Long-term Clinical Outcomes in Kidney Transplant Recipients: A Registry-based 10-year Follow-up of 5 Randomized TrialsTracey Ying, Germaine Wong, Wai H Lim, et al.
Transplantation|June 24, 2015
Cancer-Specific and All-Cause Mortality in Kidney Transplant Recipients With and Without Previous CancerAndrea K Viecelli, Wai H Lim, Petra Macaskill, et al.
Pediatric Transplantation|May 4, 2021
Paediatric deceased donor kidney transplant in Australia: A 30-year review-What have paediatric bonuses achieved and where to from here?Matthew P Sypek, Christopher E Davies, Amelia K Le Page, et al.
Clinical Transplantation|June 8, 2012
Human leukocyte antigen mismatches associated with increased risk of rejection, graft failure, and death independent of initial immunosuppression in renal transplant recipientsWai H Lim, Steve J Chadban, Philip Clayton, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|February 4, 2012
Weekend compared with weekday presentations of peritoneal dialysis-associated peritonitisDavid W Johnson, Philip Clayton, Yeoungjee Cho, et al.
JMIR Research Protocols|June 4, 2025
Using Linked Health Service Data in Multimodal Modeling of Kidney Transplant Waitlist Outcomes: Protocol for the Maximizing Organ Donor Utility Systemwide (MODUS) StudyBrenda Maria Rosales, Karan Shah, Nicole De La Mata, et al.
Nephrology (Carlton, Vic.)|January 26, 2016
Peritoneal dialysis practice in Australia and New Zealand: A call to sustain the actionDavid W Mudge, Neil Boudville, Fiona Brown, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 10, 2023
Associations of neutral pH, low-GDP peritoneal dialysis solutions with patient survival, transfer to haemodialysis and peritonitisJenny H C Chen, David W Johnson, Yeoungjee Cho, et al.
Clinical Journal of the American Society of Nephrology : CJASN|September 10, 2011
Effect of dialysis modality on survival of hepatitis C-infected ESRF patientsBhadran Bose, Stephen P McDonald, Carmel M Hawley, et al.
Pageof 4